BioPorto A/S
Managers' Transactions

November 12, 2018
Company announcement no. 21

Managers’ transactions

BioPorto A/S has received notification pursuant to article 19 of Regulation (EU) no. 596/2014 of the below transactions related to shares in BioPorto A/S made by persons discharging managerial responsibilities in BioPorto A/S and/or persons closely related with them.

 1. Details of the person discharging managerial responsibilities/person closely associated 
a) NameTherazone ApS
2 Reason for the notification 
a) Position/statusClosely associated person to Thomas Magnussen, Chairman of the Board of Directors
b) Initial notification/AmendmentInitial notification
3 Details of the issuer 
a) NameBioPorto A/S
b) LEI5299004SWFL5JAN4W830
4 Details of the transaction(s) 
a) Description of the financial instrument, type of instrument 
Identification code
Shares 
ISIN: DK0011048619
b) Nature of the transactionSubscription in connection with a private placement
c) Price(s) and volume(s)Price: DKK 3.93, Volume: 254,453
d) Aggregated informationn/a
 
e) Date of the transaction2018-11-12
f) Place of the transactionOutside a trading venue


1. Details of the person discharging managerial responsibilities/person closely associated 
a) NameTorben Arnth Nielsen
2 Reason for the notification 
a) Position/statusDeputy Chairman of the Board of Directors
b) Initial notification/AmendmentInitial notification
3 Details of the issuer 
a) NameBioPorto A/S
b) LEI5299004SWFL5JAN4W830
4 Details of the transaction(s) 
a) Description of the financial instrument, type of instrument 
Identification code
Shares 
ISIN: DK0011048619
b) Nature of the transactionSubscription in connection with a private placement
c) Price(s) and volume(s)Price: DKK 3.93, Volume: 38,168
d) Aggregated informationn/a
 
e) Date of the transaction2018-11-12
f) Place of the transactionOutside a trading venue


1. Details of the person discharging managerial responsibilities/person closely associated 
a) NameOle Larsen
2 Reason for the notification 
a) Position/statusChief Financial Officer
b) Initial notification/AmendmentInitial notification
3 Details of the issuer 
a) NameBioPorto A/S
b) LEI5299004SWFL5JAN4W830
4 Details of the transaction(s) 
a) Description of the financial instrument, type of instrument 
Identification code
Shares 
ISIN: DK0011048619
b) Nature of the transactionSubscription in connection with a private placement
c) Price(s) and volume(s)Price: DKK 3.93, Volume: 127,228
d) Aggregated informationn/a
 
e) Date of the transaction2018-11-12
f) Place of the transactionOutside a trading venue

For further information please contact:
Peter Mørch Eriksen, CEO
Gry Husby Larsen, Investor relations
Tel.: 45 29 00 00, e-mail investor@bioporto.com

Attachment